Pharmacometrics Benelux - Announcing our first event

Through this announcement, we would like to make you aware of a new initiative 
to bring together pharmacometricians in the Benelux (Belgium, Netherlands, 
Luxemburg). The intention is to create an informal platform for the 
pharmacometric community in this region of the world (in industry, academia, 
hospital pharmacies as well as regulatory bodies), with the aim to promote 
professional and scientific interactions. These are challenging times for 
pharmaceutical R&D in general, and we should all be able to benefit from 
strengthening our local network and exploring potential synergies between 
groups and individuals. We plan to kick off 'Pharmacometrics Benelux' at a 
face-to-face meeting, in which we will combine an interesting scientific 
program with ample opportunity for networking. Please mark the following date 
and time in your calendar!

When: Thursday, November 22 - 14:00 - 18:00 h
Where: Auditorium, MSD, Oss, The Netherlands
Agenda theme: Pharmacometric concepts in the development of biological products 
for immunology disorders (speakers to be announced)

More detailed information will be forthcoming in the upcoming weeks. Please 
don't hesitate to distribute this announcement further to those whom we may 
have missed.
We hope to see you in Oss on November 22!

Eugène Cox
Charlotte van Kesteren
Thomas Kerbusch
Ron Mathôt
An Vermeulen
Catherijne Knibbe
Rik de Greef
Notice:  This e-mail message, together with any attachments, contains
information of Merck & Co., Inc. (One Merck Drive, Whitehouse Station,
New Jersey, USA 08889), and/or its affiliates Direct contact information
for affiliates is available at 
http://www.merck.com/contact/contacts.html) that may be confidential,
proprietary copyrighted and/or legally privileged. It is intended solely
for the use of the individual or entity named on this message. If you are
not the intended recipient, and have received this message in error,
please notify us immediately by reply e-mail and then delete it from 
your system.

Reply via email to